Remdesivir is approved in India for restricted emergency use for the treatment of suspected or laboratory confirmed COVID-19 in adults and children hospitalised with severe disease.
Read More
He said the Delhi government will make efforts to speed-up the purchases further and administer jabs to people as soon as possible after the inoculation drive opens up on Saturday for everybody above 18.
Read More
Bharat Biotech will produce 30 million doses of its COVID-19 vaccine, Covaxin, next month against 15 million doses in March to support vaccination campaign in the country, its chairman and managing director Krishna Ella said on Tuesday.
Read More
This compared to Rs 150 per dose it charges the central government for the existing supplies.
Read More
Imports of Russia's Sputnik V vaccine are due to arrive soon and the government has also urged Pfizer, Moderna and Johnson and Johnson to sell their products to India.
Read More
India breached 200,000 daily infections for the first time on Thursday, and is trying to inoculate more of its population using domestically produced shots.
Read More
Maharashtra Chief Minister Uddhav Thackeray had earlier requested the Centre to allow the Haffkine Institute to produce Covaxin, which is currently produced by the Hyderabad-based Bharat Biotech, the official from the chief minister's office (CMO) said.
Read More
The Russian Direct Investment Fund said more than 850 million doses of Sputnik V are going to be produced annually in India -- the 60th country to approve the vaccine.
Read More
